Newsstand Menu

CRISPR-based system highlights new drug targets in a deadly leukemia


00:01:30 | March 22, 2018

Category: Research

Scientists have harnessed CRISPR, the gene-editing tool, to find highly specific dependencies in a deadly subtype of leukemia. They used an experimental drug to target these, halting cancer growth in cultured cells.

Related story

CRISPR-based system identifies important new drug targets in a deadly leukemia